chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 100.2; extreme nausea; Dizzy; severe chills; muscle aches; chest pain; headache; vomiting every 4 hours; Have not been able to eat anything but crackers; This is a spontaneous report from a contactable consumer, the patient.   A 22-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 29Mar2021 at 08:30 (at the age of 22-years-old), as dose 2, single for COVID-19 immunisation. Medical history included asthma and patient was allergic to an unspecified substance (one known). Concomitant medication within 2 weeks of vaccination included Sertraline hydrochloride (Zoloft 50 MG manufacturer unknown), trazodone (50 MG, manufacturer unknown) and fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]), all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6202 and expiration date was not reported), via an unspecified route of administration in the left leg (vaccine administered at inappropriate site) on 08Mar2021 at 14:30 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. On 29Mar2021 at 17:00, the patient had fever (100.2), extreme nausea, dizzy along with severe chills, muscle aches, chest pain and headache. On the same day, the patient had not been able to eat anything but crackers since lunch after the vaccination and had vomiting which began at midnight after the dose and ending around 11:00. Therapeutic measure taken as a result of the events experienced included ADVIL. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, extreme nausea, vomiting, had not been able to eat anything, dizzy along with severe chills, muscle aches, chest pain and headache was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a patient who was vaccinated with a dose of Gardasil and fainted, but recovered a short time after the vaccination. Additional information has been requested.
Day 1. No pain at site Day 2. No pain. Day 3. A large red painful spot surrounding the vaccine site on my left arm accidentally touched it, saw black spots in my eyes, and felt immediately nauseated.  I had to sit for over 10 minutes to attempt not to faint. Pain on my arm continued throughout the day.  Day 4. I woke up with a "hangover-like" feeling, I could not get out of bed for 4 hours after waking up initially. Pounding headaches continued until mid-day. Day 5. I feel better, the arm is barely sore. Day 6. I feel no symptoms whatsoever.
Her side effects from the Moderna COVID-19 vaccine are worse than described on the handout given to her.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Her side effects from the Moderna COVID-19 vaccine are worse than described on the handout given to her.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Her side effects from the Moderna COVID-19 vaccine are worse than described on the handout given to her.). At the time of the report, VACCINATION COMPLICATION (Her side effects from the Moderna COVID-19 vaccine are worse than described on the handout given to her.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information was not provided.   Treatment information was not provided.   Reporter did not allow further contact
My right arm at injection site has white area the size of a two dollar coin. It won't go away or tan. I am also getting heat blisters just below the injection site when sitting in the sun.
Patient is a 69 Y  male with history of COPD, Afib on Xarelto, DM2, OSA on CPAP, HYPERTENSION, HYPERLIPIDEMIA, recent COVID diagnosis 1/29/23, now presents with progressive upper and lower extremity weakness.   Patient states that on 1/25/2023 he first noticed runny nose, generalized weakness fatigue and cough.  States his symptoms were progressive and he tested positive for COVID on 1/29/2023.  States that symptoms lasted for 5 days total before resolving.   Patient states that he was prescribed Augmentin, azithromycin, and prednisone by his primary care physician on 2/4/2023 for what they believed to be bacterial pneumonia with COPD exacerbation.  Patient states subsequently he returned to his normal state of health.   Patient states on 2/7/2023 while coming home from work he first noticed weakness in the bilateral upper extremities.  States that he went to bed and upon waking up on 2/8/2023 the weakness had spread to his lower extremities and he had difficulty getting out of bed.  States that he went to emergency room on 2/8/2023 and was thought at that time to have post viral generalized fatigue and sent home.  States that this morning when he woke up the weakness was significantly worse in both the upper and lower extremities so he decided to come to alternate emergency room.   Patient states that the weakness is so severe that he has difficulty getting out of bed or ambulating.  States that he has difficulty lifting his arms at all or manipulating objects.  Denies fevers chills nausea vomiting diarrhea.  Denies bowel or bladder incontinence denies changes in sensation.  Denies changes in vision difficulty with speech difficulty understanding speech.  Denies other complaints.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications. On or about 16-AUG-2013, a pharmacist at a pharmacy administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries (dose, route, and lot # not provided). On or about 24-FEB-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered.  Causality assessment was related. Additional information has been requested.
tested positive for COVID; tested positive for COVID; This is a spontaneous report from contactable consumer.   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced tested positive for covid on an unspecified date. The events outcome was unknown. The patient was hospitalized for tested positive for covid for 14 days. The patient was hospitalized for tested positive for covid (covid-19) for 14 days. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unknown date.   Additional information:  Caller makes the comment she was with three people on 24Jul2021, inside at dinner. She was with person who was coughing their brains out but had a mask on, another person who wasn't wearing a mask, and the third person who only had one shot. All three tested positive for COVID and she was the only one who didn't. She clarifies she still has immunity obviously, and she doesn't want to get another shot. The guy next to the caller had one vaccine but he must have caught COVID from both of the other two guests at dinner. The guy next to the caller was barely masked because he was eating and talking throughout dinner, but he must have been catching COVID during that time. He didn't show any symptoms at all that night, but tested positive later. Apparently the male guest that had COVID that week was still shedding the virus because the other male guest at the dinner got COVID and was in the hospital for 2 weeks.  Caller confirms they all three tested positive for COVID. Caller declines to complete a report on these 3 people at the time of the call, requesting she would rather have her medical questions addressed at this time. No further details were provided or obtained.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Fever; Felt sick; This is a spontaneous report from a contactable consumer (patient). A 63-years-old male patient received bnt162b2 (COVID-19 VACCINE; Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient stated that he recently received his covid vaccine and afterwards, he developed a fever and felt sick. The outcome of events was unknown.  The batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Patient started feeling very lethargic the morning after receiving the vaccine. He denied having a fever. He stated that he is now feeling better (10/8/2020) and not as lethargic, but he has developed a rash on the side of the arm the size of a baseball.
Patient had second varicella vaccine on 7/25/17. States next day she began to have symptoms.  Denies respiratory difficulties.  Right arm is red at site of injection with minimal swelling. Patient denies pain, but states it is itchy. Denies using any treatment or medications, except states she put some rubbing alcohol on it. Erythema measures about 55 mm x 40 mm. Appears to have normal ROM. Examined by MD who concludes area appears c/w local inflammatory reaction; should improve on its own over next few days.
Headache, Myalgia, Nausea,Vomiting,  FATIGUE, ARM SORENESS
Patient states a few weeks after she received the vaccine she developed a painful lump under the skin at the injection site. It is still present so she presented for an office visit today.
Increasing pain L shoulder not able to move upward. Required pain meds, steroids, physical therapy, MRI Neurolgy consult.
I found out I was pregnant a couple weeks after receiving my final COVID vaccine. My last menstrual cycle was on 3/9/2021 and I had a positive pregnancy test on 4/8/2021. My last pfizer vaccine was given on 3/31/2021. My estimated date of delivery was 12/15/2021. I had a pre-natal visit at approximately 10 weeks when things appeared normal. Subsequently started passing brown mucus (5/22/2021) and then bright red blood with clots (5/28/2021). Went to the hospital and no cardiac activity was detected on ultrasound and I subsequently had a D&C on 5/29/2021. I was 11 weeks +3 days (based on LMP) when no cardiac activity was detected.
Presented with SOB/fatigue, weaknss; + covid PTA; CXR- PNA; CT: no PE, + multifocal PNA; Tx Levaquin, zithromax, Vit D3, Decadron, Lovenox, Zinc; mildly hypoxic and so she was placed on supplemental oxygen; mildly hypoxic and so she was placed on supplemental oxygen. Patient dropped O2 saturations with Walk study. Home oxygen has been arranged for patient
Urticaria, itchy skin, pain in joints, swelling & puffiness of eyes p/2nd dose in post exposure series; bitten by a dog running w/a pack; not captured;
Abscess, induration, hot, erythemia, pin point hole drainage serous fluid, fluctuance beneath wound. Pocket 1-2 cm all direction
A red raised circle the size of a quarter, it was warm to touch; A red raised circle the size of a quarter; A red raised circle the size of a quarter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (A red raised circle the size of a quarter, it was warm to touch), VACCINATION SITE ERYTHEMA (A red raised circle the size of a quarter) and VACCINATION SITE RASH (A red raised circle the size of a quarter) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Allergic reaction to Dupixent injection).  On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE WARMTH (A red raised circle the size of a quarter, it was warm to touch), VACCINATION SITE ERYTHEMA (A red raised circle the size of a quarter) and VACCINATION SITE RASH (A red raised circle the size of a quarter). At the time of the report, VACCINATION SITE WARMTH (A red raised circle the size of a quarter, it was warm to touch), VACCINATION SITE ERYTHEMA (A red raised circle the size of a quarter) and VACCINATION SITE RASH (A red raised circle the size of a quarter) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
patient reported experiencing mild throat, head and ears itching (internally) at 9pm 09/18/2019, which progressed to moderate itching, nasal congestion and cough for the next 2 days. States cough was productive with yellowish phlegm. Patient walked into our clinic Tuesday 09/24/2019 at 4pm to report occurrence, and stated she was feeling a lot better at this time, itching subsided, she was only experiencing a mild cough. States took Benadryl, nightquil and continued Zyrtec to help alleviate symptoms from 09/18 thru 09/23. Patient did not go to doctor for evaluation of symptoms and was instructed to follow up with Urgent care on 09/24/2019. Spoke to patient today and stated doing a lot better, currently experiencing mild non productive cough and does not feel the need to follow up with doctor for evaluation.
Injection site was painful and "heavy" in the first 1-3 days similar to other immunizations. On Sept 6, day 4 after the shot my left arm felt very itchy.  The site became swollen and red over the next several hours and up to the time of this report.  The swollen site is about 2.5 inches in diameter from the shot site.
Diarrhea day 2 through day 3; Left arm soreness; Left arm numbness; Redness near injected area; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 01Mar2021 at 16:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and Chiari. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 20:00, the patient experienced diarrhea day 2 through day 3, left arm soreness and numbness and redness near injected area. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was recovered on 03Mar2021; while that of the events left arm soreness and numbness and redness near injected area was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Pt came in with father and confirmed they were getting the flu vaccine and a pfizer vaccine and consents were obtained physically for covid and verbal consent for flu and pfizer booster. Pt was given the booster and  it was not indicated for a booster and RN had already given it.
Fever 102.9R responds to APAP but elevates again later; stiffens when pick him up & acts like hurts to touch; Whelps over entire body day p/immun; Seen by MD said allergic rxn & ear infection;
red spots that mom could see & feel in varying size (up to dollar size) that deel the noc of vax;lesions seen on back & on the back & on both lower extremities;seemed to be worse around site of inj;temp 100 ax;MD dx vaccine related urticari
Redness, swelling, itching.  Noted 2/17/23,  No treatment.
Patients mom allowed her 4 year old child to receive the Pfizer vaccine. No adverse events were noted.
Information has been received from a registered nurse (R.N.) concerning a 5-year-old female with no medical history or allergies who on 10-JUL-2002 was vaccinated with a first dose of Varivax. On 24-AUG-2006, he received a second dose of Varivax (lot# 653971/0796F). There was no concomitant medication. On 01-OCT-2006 the patient developed breakthrough chickenpox. Medical attention was sought and her chickenpox were described as "30 spots on her abdomen and legs". No laboratory or diagnostic studies were performed. At the time of the report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Morning after sever metallic taste whenever my tongue contacted anything such as food, drink, lips, roof of mouth or teeth.  Severity unchanged for two days and beginning to wane as of this writing.  All other senses normal.  Slight malaise two days after but otherwise no other health anomalies.
Shingles after I received the shingles shot/suspected vaccination failure; Shingles; Itchy; Hot flame torches up my back/Red hot; Scary skin; No sleep; Misery; Red; Oozing sore; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Shingles after I received the shingles shot/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), pruritus (Verbatim: Itchy), feeling hot (Verbatim: Hot flame torches up my back/Red hot), skin disorder (Verbatim: Scary skin), insomnia (Verbatim: No sleep), feeling miserable (Verbatim: Misery), erythema (Verbatim: Red) and pain (Verbatim: Oozing sore). The patient was treated with calamine. The outcome of the vaccination failure was unknown and the outcome of the shingles, pruritus, feeling hot, insomnia and erythema were not reported and the outcome of the skin disorder and feeling miserable were recovered/resolved and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pruritus, feeling hot, skin disorder, insomnia, feeling miserable, erythema and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pruritus, feeling hot, skin disorder, insomnia, feeling miserable, erythema and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 12-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she received Shingles vaccine and experienced shingles which was began at the night. The patient stated that it was itchy hot flame torches ran up his/her back. The patient had scary skin for a full month and did not had sleep constantly. The patient applying calamine lotion as a treatment. The pharmacy medic stated that the vaccine was not a live virus so it was not to blame. The patient experienced full month of misery and it was his/her punishment. The patient had red hot and oozing sore. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Pt. called pharmacy on 10/24 approx 7:00 pm stating she had received vaccination previous day and now complaining of numbness and tingling in both arms. I contacted her on 10/25 in morning and she said upon awakening no longer any symptoms. She however feels like she now has the flu.
tinnitus shortly after my second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 06Apr2021 08:30 (Lot number: EP7533) at the age of 50 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (location=Right arm, administration time=08:15AM, lot no: EN6204, dose number=1), administration date: 16Mar2021, when the patient was 50 years old, for COVID-19 Immunization. The following information was reported: TINNITUS (non-serious) with onset Apr2021, outcome "recovering", described as "tinnitus shortly after my second dose". Additional information: Experienced tinnitus and plugged up right ear shortly after the second dose. symptoms took months to go away, through not completely. No other vaccine in four weeks. No other medications in two weeks. No COVID prior vaccination. COVID test type post vaccination=Nasal Swab. COVID test date=21Oct2021. COVID test result=Negative. No known allergies.  No follow-up attempts are possible. No further information is expected.
patient with vasovagal response following vaccine vital signs obtained, lying BP 127/80 HR 78, R 16 Pulse ox 100% on room air, sitting patient was 111/77 and standing patient bp was 109/73- patient was released to the exit via wheelchair with no additional intervention other than additional monitoring
A report was received from a health care professional on 11/13/03 concerning a 84 year old female vaccinee who inadvertently received 2 doses of Fluvirin, one on 11/13/03 and the other on an unspecified date. On 11/13/03, the vaccinee received Fluvirin, on another unspecified date another nurse administered Fluvirin to the vaccinee. The vaccinee had not experienced any adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sudden hearing loss.  Head feels like I'm in an airplane, but ears won't "unblock." Taste loss as well.